Magnetic particle imaging

Studio Portrait in Your Pocket: vivo Launches V29 with Unique Aura Light, Chic Design and Enhanced Performance

Retrieved on: 
Sunday, August 13, 2023
Temperature, Life, Smartphone, 3D, EIS, Light, Metaphor, Qualcomm, History, Photography, SGS, Creativity, IP68, Motion, OIS, Vivo, UV, Dust, MP, Never Will, Glass, TYP, System, Magnetic particle imaging, Imagination, Environment, Social media, Rain, Telescopic sight, Camera, Television, V29

"vivo is constantly striving to develop leading technology such as the studio-level portrait in its smartphones to improve portrait photography and overall user experience.

Key Points: 
  • "vivo is constantly striving to develop leading technology such as the studio-level portrait in its smartphones to improve portrait photography and overall user experience.
  • With the Aura Light feature, V29 continues to push boundaries in the pursuit of excellence, while prioritizing the needs of users at the same time.
  • Recognizing the vital role of light in capturing stunning images, the rear camera of V29 is equipped with the largest Aura Light in vivo's history.
  • With just a single tap on V29, subjects in dimly lit environments are gently illuminated, allowing their unique characteristics to shine through.

New Image Reconstruction Model for MPI to be Presented by Magnetic Insight Scientist at International Workshop

Retrieved on: 
Wednesday, March 22, 2023
International Workshop on 1 & 2 Dimensional Magnetic Measurement and Testing, MPI, Magnetic particle imaging, Research, Q&A, Medical imaging

ALAMEDA, Calif., March 22, 2023 /PRNewswire/ -- Dr. Toby Sanders, a computational scientist at Magnetic Insight, will be delivering a presentation titled "A New Image Reconstruction Model for MPI based on X-space Theory" at the International Workshop on Magnetic Particle Imaging (IWMPI) in Aachen, held in Germany from March 22-24.

Key Points: 
  • ALAMEDA, Calif., March 22, 2023 /PRNewswire/ -- Dr. Toby Sanders, a computational scientist at Magnetic Insight, will be delivering a presentation titled "A New Image Reconstruction Model for MPI based on X-space Theory" at the International Workshop on Magnetic Particle Imaging (IWMPI) in Aachen, held in Germany from March 22-24.
  • The talk will introduce a new model for MPI image reconstruction that promises to significantly improve image quality.
  • As the leader in MPI hardware sales worldwide, Magnetic Insight's innovative approach to research and development has led to major advancements in theoretical insights and computational techniques.
  • "We are thrilled to unveil this new image reconstruction model for MPI," says Dr. Sanders.

Preclinical Imaging Global Market Report 2023: Sector to Reach $3.93 Billion by 2030 at a 6.51% CAGR

Retrieved on: 
Monday, January 23, 2023
Photon, Reagent, Modality, Drug discovery, Research, Private, Single-photon emission computed tomography, Strategic management, Market share analysis, Use, Magnetic resonance imaging, Positron emission tomography, Pathfinder, Institute for Governance of Private and Public Organizations, Magnetic particle imaging, COVID-19, Application, MRI, Business Growth Fund, User (computing), Value, Optical flow, Customer support, Medical imaging, Pharmaceutical industry, Retail

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Preclinical Imaging Market.

Key Points: 
  • The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Preclinical Imaging Market.
  • The Global Preclinical Imaging Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.
  • What is the market share of the leading vendors in the Global Preclinical Imaging Market?
  • What modes and strategic moves are considered suitable for entering the Global Preclinical Imaging Market?

Preclinical Imaging Global Market Report 2023: Increasing Adaptation of Diagnostic Imaging Bolsters Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 19, 2023
Health Technology, Health, Clinical Trials, Photon, Value, Private, Modality, Customer support, Use, COVID-19, Optical flow, Positron emission tomography, Reagent, Market share analysis, Pathfinder, User (computing), Strategic management, Application, Magnetic particle imaging, Single-photon emission computed tomography, Magnetic resonance imaging, MRI, Drug discovery, Business Growth Fund, Research, Institute for Governance of Private and Public Organizations, Medical imaging, Fine chemical, Retail

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Preclinical Imaging Market.

Key Points: 
  • The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Preclinical Imaging Market.
  • The Global Preclinical Imaging Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.
  • What is the market share of the leading vendors in the Global Preclinical Imaging Market?
  • What modes and strategic moves are considered suitable for entering the Global Preclinical Imaging Market?

New Momentum Magnetic Particle Imaging Scanner Has Been Installed in Los Angeles County

Retrieved on: 
Tuesday, October 11, 2022
Momentum, Physician, Nuclear medicine, Hospital, Magnetic particle imaging, National Comprehensive Cancer Network, U.S. News & World Report, National Cancer Institute, Research, Program, MRI, Technology, Cancer, CT, MPI, Immune system, Development of the human body, CEO, University, Diabetes, U.S. News & World Report Best Hospitals Rankings, News, Decision-making, City, PET, City of Hope, Medical imaging, Hope

The scanner will be housed at City of Hope's pre-clinical research facilities in Los Angeles.

Key Points: 
  • The scanner will be housed at City of Hope's pre-clinical research facilities in Los Angeles.
  • The Momentum MPI scanner enables preclinical testing of the imaging protocols and cell therapies being translated to clinical research applications by capturing pathophysiology currently invisible to traditional imaging techniques.
  • While Magnetic Insight has shipped pre-clinical imagers worldwide, they are now scaling MPI technology to clinical scale.
  • Magnetic Insight has pioneered magnetic particle imaging (MPI), a new diagnostic and monitoring technology that transforms medical imaging.

Magnetic Insight Raises $17M Series B to Expand Magnetic Particle Imaging and Monitoring Technology into Clinical Applications

Retrieved on: 
Thursday, June 23, 2022
Momentum, Doctor of Philosophy, Computer Sciences, NK, CTO, Nuclear medicine, Wenzhou Medical University, University of New South Wales, Technology, Lymphoma, CEO, Robarts Research Institute, Johns Hopkins University, Biological engineering, Stanford University School of Medicine, Cancer, Cook, Growth, Karolinska Institute, Physician, Lymphatic system, University, CT, University of Florida, Celesta, MRI, Leukemia, MPI, Magnetic particle imaging, Patient, Academic health science centre, Health, Electricity, University of California, Berkeley, Michigan State University, Medical imaging

ALAMEDA, Calif., June 23, 2022 /PRNewswire/ -- Imaging diagnostics company Magnetic Insight today announced $17 million in Series B funding led by Celesta Capital, with participation from Alumni Ventures Group, Gaingels, and others, along with existing investors 5AM Ventures and Sand Hill Angels. The funding will support Magnetic Insight's continued growth and expansion of its innovative Magnetic Particle Imaging (MPI) technology into clinical applications.

Key Points: 
  • The funding will support Magnetic Insight's continued growth and expansion of its innovative Magnetic Particle Imaging (MPI) technology into clinical applications.
  • Magnetic Insight's goal is to offer clinicians a method to directly monitor cell therapy, enabling better and earlier clinical decisions, and optimal clinical outcomes.
  • Magnetic Insight has pioneered magnetic particle imaging (MPI), a new diagnostic and monitoring technology that transforms medical imaging.
  • Having started in the preclinical space by selling small animal products to leading universities worldwide, Magnetic Insight is now scaling up MPI technology for clinical use.

Magnetic Insight Awarded NIH SBIR grant to Advance In Vivo Biosensing Through Color Magnetic Particle Imaging

Retrieved on: 
Friday, October 2, 2020
Imaging, Magnetic particle imaging, Electromagnetism, Magnetic nanoparticles, MPI, Medical imaging, Optics, Vision

ALAMEDA, Calif., Oct. 2, 2020 /PRNewswire/ --Magnetic Insight, Inc., the leader in magnetic particle imaging (MPI) solutions, is pleased to announce it was awarded a Fast-Track Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).

Key Points: 
  • ALAMEDA, Calif., Oct. 2, 2020 /PRNewswire/ --Magnetic Insight, Inc., the leader in magnetic particle imaging (MPI) solutions, is pleased to announce it was awarded a Fast-Track Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).
  • The project, "Color MPI as a Novel Method for in vivo Assessment of Magnetic Nanoparticle Dynamics and Binding," proposes a new imaging method called "Color MPI (c-MPI)," which can add new image contrast to MPI images.
  • Magnetic Insight is an early stage diagnostic imaging company accelerating preclinical research with direct translation into the clinic.
  • Magnetic Particle Imaging (MPI) is an ultrasensitive, safe, and quantitative technology built on high-contrast detection of iron-oxide nanoparticles.

Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer

Retrieved on: 
Monday, October 14, 2019
Magnetism, Imaging, Magnetic particle imaging, Magnetic nanoparticles, MPI, Magnet

ALAMEDA, Calif., Oct. 14, 2019 /PRNewswire/ -- Magnetic Insight, Inc., the leader in Magnetic Particle Imaging (MPI) solutions, announced today that David Panzarella has been appointed as the company's Chief Commercial Officer.

Key Points: 
  • ALAMEDA, Calif., Oct. 14, 2019 /PRNewswire/ -- Magnetic Insight, Inc., the leader in Magnetic Particle Imaging (MPI) solutions, announced today that David Panzarella has been appointed as the company's Chief Commercial Officer.
  • With over 25 years of sales experience, Mr. Panzarella is a commercial leader in new technology market development and corporate growth.
  • He has a proven track record for growing companies and leading teams" said Anna Christensen, President and CEO of Magnetic Insight.
  • Magnetic Insight's flagship technology is Magnetic Particle Imaging (MPI), a method for imaging magnetic nanoparticles with no depth attenuation and with incredible sensitivity and specificity.

NIH SBIR Grant Awarded to Accelerate Magnetic Particle Imaging in Cancer Immunology

Retrieved on: 
Monday, September 30, 2019
Medicine, Medical specialties, Branches of biology, Imaging, Magnetic particle imaging, Medical physics, Medical imaging, Inflammation, Combinatorial ablation and immunotherapy, Magnetic nanoparticles

During the twelve-month project, entitled "Development of a commercial Magnetic Particle Imaging platform for the detection and quantification of localized inflammation in cancer," Magnetic Insight will develop new cancer immunology tools for visualizing inflammation.

Key Points: 
  • During the twelve-month project, entitled "Development of a commercial Magnetic Particle Imaging platform for the detection and quantification of localized inflammation in cancer," Magnetic Insight will develop new cancer immunology tools for visualizing inflammation.
  • Localized inflammation is an attractive diagnostic imaging target for a variety of diseases and conditions, including traumatic injury, stroke, auto-immune diseases, and cancer.
  • "Magnetic particle imaging is enabling new insights into cancer immunology by tracking therapeutic cells, identifying inflammation due to immune activation, and with targeted hyperthermia.
  • Magnetic Particle Imaging (MPI) is an ultrasensitive, safe, and quantitative technology built on high-contrast detection of iron-oxide nanoparticles.

Magnetic Insight Introduces MOMENTUM CT, the First Commercial Magnetic Particle Imaging (MPI) System with Integrated X-ray Computed Tomography (CT)

Retrieved on: 
Tuesday, September 3, 2019
Medical physics, Imaging, Magnetic particle imaging, Medicine, Nuclear medicine, Image processing, Medical imaging, Applied sciences, Tomography, Optics, MPI, Iron oxide nanoparticle

ALAMEDA, Calif., Sept. 3, 2019 /PRNewswire/ --Magnetic Insight, Inc., the leader in magnetic particle imaging (MPI) solutions, introduces the first commercially available MPI system with integrated X-ray computed tomography (CT), offering anatomical context to the newest breakthrough molecular imaging modality.

Key Points: 
  • ALAMEDA, Calif., Sept. 3, 2019 /PRNewswire/ --Magnetic Insight, Inc., the leader in magnetic particle imaging (MPI) solutions, introduces the first commercially available MPI system with integrated X-ray computed tomography (CT), offering anatomical context to the newest breakthrough molecular imaging modality.
  • The MOMENTUM MPI system can now be installed as a base system or with an integrated CT module.
  • Magnetic Insight is an early stage diagnostic imaging company accelerating preclinical research with direct translation into the clinic.
  • Magnetic Particle Imaging (MPI) is an ultrasensitive, safe and quantitative technology, harnessing high contrast detection of iron oxide nanoparticles.